Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1,278 subjects.
D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D000871:Anthelmintics / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D002219:Carbamates / Q000627:therapeutic use; D002247:Carbon Isotopes; D002648:Child; D003106:Colon / Q000378:metabolism; D004757:Enterobius / Q000302:isolation & purification; D005188:False Negative Reactions; D005947:Glucose / Q000378:metabolism; D006801:Humans; D010123:Oxyuriasis / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D010919:Placebos; D011774:Pyrvinium Compounds / Q000627:therapeutic use; D013997:Time Factors; D014481:United States
D000871:Anthelmintics; D001562:Benzimidazoles; D001565:Benzoates; D002219:Carbamates; D002247:Carbon Isotopes; D010919:Placebos; D011774:Pyrvinium Compounds; D005947:Glucose